Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines현재 사용 가능한 COVID-19 백신에 저항할 가능성이 있는 새로 분류된 관심 변종인 SARS-CoV-2 Mu에 대처하기 위한 전략Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), MERS, SARS, 변종, 유전자 메커니즘, 진단, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 administration adopted approach B.1 lineage B.1.621 BNT161b2 booster dose Characteristics coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccine COVID-19 vaccine development Evidence exacerbated Genetic genomic Genomic surveillance global mass vaccination Health implementation infections Intervention Lineage mass vaccination Mu variant mutations Neutralizing non-pharmaceutical interventions (NPIs) NPIs potential risk public health measure public health measures Recombination reported required respiratory restrict SARS-CoV-2 SARS-CoV-2 B.1.621 SARS-CoV-2 virus sera shown Strains Strategy sub-lineage B.1.621.1 Surveillance survivor the SARS-CoV-2 virus therapeutic threat vaccination Vaccine vaccine breakthrough. Vaccine development variant variants [DOI] 10.1080/21645515.2022.2027197 PMC 바로가기 [Article Type] Article
Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern in real-world: a literature review and meta-analysisArticle Published on 2022-12-012022-11-16 Journal: Emerging Microbes & Infections [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI Analysis Beta booster vaccination caused Clinical outcome collected Coverage COVID-19 vaccine COVID-19 vaccine effectiveness declined Delta driven by Effectiveness eligibility criteria evaluated Evolution Gamma Hospitalization Infection literature review Meta-analysis meta-regression moderate omicron protective vaccine provided public health public health measures Real-world study SARS-CoV-2 SARS-CoV-2 variant searched severe disease supported vaccination Vaccine variant variants of concern variants of concern. virus VoC VOCs [DOI] 10.1080/22221751.2022.2122582 PMC 바로가기
Population-based screening in a municipality after a primary school outbreak of the SARS-CoV-2 Alpha variant, the Netherlands, December 2020-February 2021Article Published on 2022-10-272022-11-16 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] age Alpha Alpha variant Analysis caused children circulation Clinical symptoms confounders epidemiological link individual infected individual infected individuals Laboratory Lineage B.1.1.7 Netherlands not significantly different outbreak PCR Prevent public health measures questionnaire SAR SARS-CoV-2 SARS-CoV-2 variant School Schools secondary attack rate self-reported symptom sequence Sequencing spread to the mean the SARS-CoV-2 Transmission variant virus virus transmission was determined was used whole genome [DOI] 10.1371/journal.pone.0276696 PMC 바로가기
A Robust, Highly Multiplexed Mass Spectrometry Assay to Identify SARS-CoV-2 VariantsArticle Published on 2022-10-262022-11-15 Journal: Microbiology Spectrum [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, 치료제, [키워드] acute respiratory syndrome Care characterized circulation Clinical studies collected coronavirus defined Delta demonstrated diagnostic diagnostic capability effort functional health system health systems identify increasingly Infection prevention Iota Laboratory MALDI-TOF mass molecular MOST multiplex New York City omicron Panel Patient Patient care polymorphism Population public health measures public health systems RNA robust RT-PCR SARS-CoV-2 SARS-CoV-2 lineage SARS-CoV-2 variant seeking sensitivity specificity specimen Spectrometry Surveillance target tested Transmissibility USA utility vaccination variant variant call variant panel. virus WGS while whole-genome sequencing [DOI] 10.1128/spectrum.01736-22 PMC 바로가기
SARS-CoV-2 variants of concern and spike protein mutational dynamics in a Swedish cohort during 2021, studied by Nanopore sequencingArticle Published on 2022-10-182022-11-15 Journal: Virology Journal [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] A222V analysed approach ARTIC Network assist bioinformatics can be used circulating variant Cohort COVID-19 COVID-19 pandemic Delta delta variant distribution genomic Health include less mapped Mutation mutations nanopore sequencing National occurred omicron Patient positive primer Protein public health public health measures Q677H S protein SARS-CoV-2 SARS-CoV-2 genomes SARS-CoV-2 variant sequence Sequencing sequencing method spike Spike protein Surveillance Swedish the S protein the SARS-CoV-2 the Spike Uppsala County variant variants variants of concern. variants of interest VoC whole-genome sequencing [DOI] 10.1186/s12985-022-01896-x PMC 바로가기
Real-time estimation of the effective reproduction number of SARS-CoV-2 in Aotearoa New ZealandArticle Published on 2022-10-172023-07-10 Journal: PeerJ [Category] COVID19(2023년), [키워드] Bayesian inference COVID-19 delta variant Non-pharmaceutical interventions public health measures Reproduction number SARS-CoV-2. [DOI] 10.7717/peerj.14119 PMC 바로가기
Transmission of SARS-CoV-2 in a primary school setting with and without public health measures using real-world contact data: A modelling studyArticle Published on 2022-10-012022-11-16 Journal: Journal of Global Health [Category] COVID19(2023년), SARS, 변종, [키워드] 95% CI 95% confidence interval absence average B.1.1.529 B.1.1.7 B.1.617.2 close contact Contact COVID-19 pandemic Delta demonstrated distribution Face mask Frequency Health higher risk Incubation period index case index cases infected individual investigated measure omicron onward transmission per day physical physical distance physical distancing potential transmission predict Probability Public public health measure public health measures reducing risk SARS-CoV-2 SARS-CoV-2 transmission School shown significantly higher the SARS-CoV-2 Transmission transmission of SARS-CoV-2 variant variants were used while [DOI] 10.7189/jogh.12.05034 PMC 바로가기
External quality assessment of SARS-CoV-2 serology in European expert laboratories, April 2021Article Published on 2022-10-012022-11-15 Journal: Eurosurveillance [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] anti-SARS-CoV-2 antibodies anti-SARS-CoV-2 antibody antibodies characterisation collected composed country COVID-19 Critical detect Diagnosis diagnostics eight epidemiological EQA Europe European evaluate External human SARS-CoV-2 human serum immune response Immunoglobulin indicated involved Laboratory mitigate natural infection neutralising antibody participant performed provided public health measures robust SARS-CoV-2 SARS-CoV-2 antibody SARS-CoV-2 antibody responses SARS-COV-2 infection SARS-CoV-2 pandemic SARS-CoV-2 transmission Sensitivity and specificity serological serological test serology Serology. Support the vaccine Vaccine [DOI] 10.2807/1560-7917.ES.2022.27.42.2101057 PMC 바로가기
Public health genomics capacity assessment: readiness for large-scale pathogen genomic surveillance in Canada’s public health laboratoriesArticle Published on 2022-09-242022-11-16 Journal: BMC Public Health [Category] SARS, 유전자 메커니즘, [키워드] bioinformatics Canada Capacity capacity building Contact tracing COVID-19 diagnostic Diseases early stage effective genomic Genomics Health Laboratory pandemic pathogen Public public health Public health laboratory public health measures Research resource SARS-CoV-2 SARS-CoV-2 genome sequencing SARS-CoV-2 genomic surveillance specimen Study design Surveillance surveillance. unique Variability [DOI] 10.1186/s12889-022-14210-9 PMC 바로가기
Evolving trend change during the COVID-19 pandemicArticle Published on 2022-09-202022-11-16 Journal: Frontiers in Public Health [Category] SARS, 변종, [키워드] African caused country COVID-19 COVID-19 pandemic death disease driving early stage Epidemics epidemics evolve epidemiological Europe Factors feasibility First wave Geographic distribution highest indicated Infection initial Lineage lowest omicron pandemic Prevent provide public health public health measures reducing reduction in severity single vaccine South America spatiotemporal Spread spread of COVID-19 Structure the disease the vaccine Transmissibility vaccination vaccination rate Vaccinations Vaccine variant variants variants. [DOI] 10.3389/fpubh.2022.957265 PMC 바로가기